vs
Dayforce（DAY）与ICU MEDICAL INC（ICUI）财务数据对比。点击上方公司名可切换其他公司
ICU MEDICAL INC的季度营收约是Dayforce的1.1倍（$540.7M vs $481.6M），ICU MEDICAL INC净利率更高（-2.9% vs -40.9%，领先38.0%），Dayforce同比增速更快（9.5% vs -14.1%），过去两年Dayforce的营收复合增速更高（9.8% vs -2.3%）
Dayforce前身为知名人力资源服务商Ceridian，是一家总部位于美国的人力资源软件及服务企业，面向各行业不同规模的客户提供覆盖薪酬核算、人员管理、考勤等多场景的HR SaaS产品及配套专业服务，助力企业提升人力资源运营效率。
ICU医疗是总部位于美国加利福尼亚州圣克莱门特的医疗科技企业，专注于研发预防血流感染、保护医护人员免受传染病或危险药物侵害的医疗产品，产品线覆盖静脉治疗用品、输液泵、无针血管通路设备、定制输液套装、危险药物密闭处理系统、传感导管以及无针封闭式血液采样系统等。
DAY vs ICUI — 直观对比
营收规模更大
ICUI
是对方的1.1倍
$481.6M
营收增速更快
DAY
高出23.6%
-14.1%
净利率更高
ICUI
高出38.0%
-40.9%
两年增速更快
DAY
近两年复合增速
-2.3%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $481.6M | $540.7M |
| 净利润 | $-196.8M | $-15.7M |
| 毛利率 | — | 37.5% |
| 营业利润率 | 6.3% | 1.0% |
| 净利率 | -40.9% | -2.9% |
| 营收同比 | 9.5% | -14.1% |
| 净利润同比 | -9940.0% | 34.0% |
| 每股收益（稀释后） | $-1.23 | $-0.63 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DAYICUI
| Q4 25 | — | $540.7M | ||
| Q3 25 | $481.6M | $537.0M | ||
| Q2 25 | $464.7M | $548.9M | ||
| Q1 25 | $481.8M | $604.7M | ||
| Q4 24 | $465.2M | $629.8M | ||
| Q3 24 | $440.0M | $589.1M | ||
| Q2 24 | $423.3M | $596.5M | ||
| Q1 24 | $431.5M | $566.7M |
净利润DAYICUI
| Q4 25 | — | $-15.7M | ||
| Q3 25 | $-196.8M | $-3.4M | ||
| Q2 25 | $21.3M | $35.3M | ||
| Q1 25 | $14.9M | $-15.5M | ||
| Q4 24 | $10.8M | $-23.8M | ||
| Q3 24 | $2.0M | $-33.0M | ||
| Q2 24 | $-1.8M | $-21.4M | ||
| Q1 24 | $7.1M | $-39.5M |
毛利率DAYICUI
| Q4 25 | — | 37.5% | ||
| Q3 25 | — | 37.4% | ||
| Q2 25 | — | 37.9% | ||
| Q1 25 | — | 34.7% | ||
| Q4 24 | 47.0% | 36.1% | ||
| Q3 24 | 45.8% | 34.8% | ||
| Q2 24 | 44.1% | 34.8% | ||
| Q1 24 | 47.6% | 32.7% |
营业利润率DAYICUI
| Q4 25 | — | 1.0% | ||
| Q3 25 | 6.3% | 2.6% | ||
| Q2 25 | 9.1% | 1.9% | ||
| Q1 25 | 6.4% | 2.1% | ||
| Q4 24 | 6.1% | 6.0% | ||
| Q3 24 | 4.7% | 1.4% | ||
| Q2 24 | 3.3% | 1.3% | ||
| Q1 24 | 9.4% | -1.9% |
净利率DAYICUI
| Q4 25 | — | -2.9% | ||
| Q3 25 | -40.9% | -0.6% | ||
| Q2 25 | 4.6% | 6.4% | ||
| Q1 25 | 3.1% | -2.6% | ||
| Q4 24 | 2.3% | -3.8% | ||
| Q3 24 | 0.5% | -5.6% | ||
| Q2 24 | -0.4% | -3.6% | ||
| Q1 24 | 1.6% | -7.0% |
每股收益（稀释后）DAYICUI
| Q4 25 | — | $-0.63 | ||
| Q3 25 | $-1.23 | $-0.14 | ||
| Q2 25 | $0.13 | $1.43 | ||
| Q1 25 | $0.09 | $-0.63 | ||
| Q4 24 | $0.07 | $-0.97 | ||
| Q3 24 | $0.01 | $-1.35 | ||
| Q2 24 | $-0.01 | $-0.88 | ||
| Q1 24 | $0.04 | $-1.63 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $627.6M | — |
| 总债务越低越好 | $631.1M | — |
| 股东权益账面价值 | $2.7B | $2.1B |
| 总资产 | $8.7B | $4.1B |
| 负债/权益比越低杠杆越低 | 0.23× | — |
8季度趋势，按日历期对齐
现金及短期投资DAYICUI
| Q4 25 | — | — | ||
| Q3 25 | $627.6M | — | ||
| Q2 25 | $625.2M | — | ||
| Q1 25 | $557.3M | — | ||
| Q4 24 | $579.7M | $308.6M | ||
| Q3 24 | $494.1M | $312.5M | ||
| Q2 24 | $465.4M | $302.6M | ||
| Q1 24 | $392.5M | $251.4M |
总债务DAYICUI
| Q4 25 | — | — | ||
| Q3 25 | $631.1M | — | ||
| Q2 25 | $631.8M | — | ||
| Q1 25 | $632.4M | — | ||
| Q4 24 | $1.2B | — | ||
| Q3 24 | $1.2B | — | ||
| Q2 24 | $1.2B | — | ||
| Q1 24 | $1.2B | — |
股东权益DAYICUI
| Q4 25 | — | $2.1B | ||
| Q3 25 | $2.7B | $2.1B | ||
| Q2 25 | $2.7B | $2.1B | ||
| Q1 25 | $2.6B | $2.0B | ||
| Q4 24 | $2.5B | $2.0B | ||
| Q3 24 | $2.6B | $2.0B | ||
| Q2 24 | $2.5B | $2.0B | ||
| Q1 24 | $2.4B | $2.1B |
总资产DAYICUI
| Q4 25 | — | $4.1B | ||
| Q3 25 | $8.7B | $4.1B | ||
| Q2 25 | $8.5B | $4.1B | ||
| Q1 25 | $9.5B | $4.2B | ||
| Q4 24 | $9.1B | $4.2B | ||
| Q3 24 | $8.1B | $4.3B | ||
| Q2 24 | $9.0B | $4.3B | ||
| Q1 24 | $10.8B | $4.3B |
负债/权益比DAYICUI
| Q4 25 | — | — | ||
| Q3 25 | 0.23× | — | ||
| Q2 25 | 0.23× | — | ||
| Q1 25 | 0.24× | — | ||
| Q4 24 | 0.47× | — | ||
| Q3 24 | 0.47× | — | ||
| Q2 24 | 0.49× | — | ||
| Q1 24 | 0.50× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $31.2M | $60.6M |
| 自由现金流经营现金流 - 资本支出 | — | $36.0M |
| 自由现金流率自由现金流/营收 | — | 6.6% |
| 资本支出强度资本支出/营收 | — | 4.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $91.8M |
8季度趋势，按日历期对齐
经营现金流DAYICUI
| Q4 25 | — | $60.6M | ||
| Q3 25 | $31.2M | $56.7M | ||
| Q2 25 | $112.7M | $11.2M | ||
| Q1 25 | $49.6M | $51.3M | ||
| Q4 24 | $81.0M | $40.2M | ||
| Q3 24 | $91.8M | $36.1M | ||
| Q2 24 | $99.2M | $82.0M | ||
| Q1 24 | $9.1M | $45.8M |
自由现金流DAYICUI
| Q4 25 | — | $36.0M | ||
| Q3 25 | — | $27.6M | ||
| Q2 25 | — | $-8.5M | ||
| Q1 25 | — | $36.7M | ||
| Q4 24 | — | $16.1M | ||
| Q3 24 | — | $16.2M | ||
| Q2 24 | — | $62.5M | ||
| Q1 24 | — | $29.9M |
自由现金流率DAYICUI
| Q4 25 | — | 6.6% | ||
| Q3 25 | — | 5.1% | ||
| Q2 25 | — | -1.5% | ||
| Q1 25 | — | 6.1% | ||
| Q4 24 | — | 2.6% | ||
| Q3 24 | — | 2.7% | ||
| Q2 24 | — | 10.5% | ||
| Q1 24 | — | 5.3% |
资本支出强度DAYICUI
| Q4 25 | — | 4.6% | ||
| Q3 25 | — | 5.4% | ||
| Q2 25 | — | 3.6% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | — | 3.8% | ||
| Q3 24 | — | 3.4% | ||
| Q2 24 | — | 3.3% | ||
| Q1 24 | — | 2.8% |
现金转化率DAYICUI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 5.29× | 0.32× | ||
| Q1 25 | 3.33× | — | ||
| Q4 24 | 7.50× | — | ||
| Q3 24 | 45.90× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 1.28× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DAY
| Dayforce Recurring | $333.0M | 69% |
| Cloud And Bureau Professional Services And Other | $78.5M | 16% |
| Float | $42.2M | 9% |
| Powerpay Recurring | $19.7M | 4% |
| Other Recurring | $8.2M | 2% |
ICUI
| Infusion Consumables | $284.7M | 53% |
| Infusion Systems | $176.3M | 33% |
| Vital Care | $79.7M | 15% |
